Navigation Links
Replidyne's Investigational Antibacterial Agent REP3123 Prevents Sporulation in Clostridium difficile
Date:9/19/2007

l forward-looking statements made in the press release are made as of the date hereof and the Company assumes no obligation to update the forward-looking statements in the document.


'/>"/>
SOURCE Replidyne, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
3. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
4. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
5. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
6. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
7. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
9. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
10. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
11. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Inc.,today announced that it was awarded the 2009 ... New England Venture Summit, held on December 8th,at ... private companies,driving the future of innovation, was granted ... held companies that play a leading role in ... , "We are honored ...
(Date:12/16/2009)... N.J. and ANN ARBOR, Mich., Dec. 16 /PRNewswire-FirstCall/ ... ) and NanoBio Corporation today announced an exclusive ... for the over-the-counter (OTC) use of NB-001, a ... the treatment of cold sores. Developed by NanoBio, ... that causes cold sores, herpes labialis . ...
(Date:12/16/2009)... MAQUET Cardiovascular LLC, a leading ... it has signed a three-year single source ... supply contracting company, for MAQUET,s market-leading VASOVIEW ... products assist healthcare providers in obtaining veins ... only small incisions. This allows for faster ...
Breaking Medicine Technology:Biovista Inc. Named Top Innovator in Life Sciences 2GlaxoSmithKline and NanoBio Announce OTC Licensing Agreement for Cold Sore Treatment 2MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 2MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 3MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 449th ICAAC press kit now available online 9848 1New Vaccine May Work Better Against Lung Disease 56647 1New Vaccine May Work Better Against Lung Disease 56647 2Misonix Announces New Sales Agency Agreement for Middle East India and Pakistan 13947 1Misonix Announces New Sales Agency Agreement for Middle East India and Pakistan 13947 2Misonix Announces New Sales Agency Agreement for Middle East India and Pakistan 13947 3
... (Nasdaq: PRXL ), a leading global ... opened an office in Lima, Peru to provide ... addition of the Peru office, PAREXEL now has ... America, which also include Argentina, Brazil, Chile, and ...
... St. Jude scientists report basic findings on critical enzyme,s regulation may ... disorders , , MEMPHIS, Tenn., Nov. ... gained new insights into regulation of one of the body,s enzyme ... As the cell,s molecular overachievers, calpains function in many cellular processes, ...
Other Medicine Technology:PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3
(Date:12/16/2009)... Losing has never felt so good for ... healthy new lifestyle means continuing to make smart choices ... milk is one healthy choice that is an important ... everyone can take. Every glass of milk has nine ... help maintain normal blood pressure, and calcium and vitamin ...
(Date:12/16/2009)... HealthSciences Institute will sponsor a new learning ... organizations who serve individuals at risk of, ... health plan, medical home and other provider ... noncommercial webinars on topics, solutions and case ... care improvement. Each webinar will include a ...
(Date:12/16/2009)... advance that could help ease health and environmental concerns ... of technology for changing the behavior of nanoparticles in ... the environment. Their study was published in ACS, journal ... from the UK Centre for Ecology and Hydrology and ... production of nanoparticles particles less than 1/1000th the ...
(Date:12/16/2009)... half, but use in humans is still far off , , ... nature, researchers have built and tested synthetic versions of the ... other cases where blood just won,t stop flowing. , "We ... in degradable stitches, which dissolve in the body," said Erin ... Reserve University, and lead author of a report published ...
(Date:12/16/2009)... not be determining factor for use, expert says, , , ... heart failure are much less likely to die when ... study. , The study included 4,685 people, ages 65 ... had a left ventricular fraction (a measure of the ... During a three-year period, those who were treated with ...
Breaking Medicine News(10 mins):Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 2Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 3Health News:Behavior modification could ease concerns about nanoparticles 2Health News:Synthetic Platelets Put the Brakes on Blood Loss 2Health News:Synthetic Platelets Put the Brakes on Blood Loss 3Health News:Implanted Defibrillator Might Extend Life 2
... Scientists have for the first time identified brain sites ... In a study comparing brain activity of sober alcoholics ... sober alcoholics showed significantly more "impulsive" neural activity. , ... boosted activity in these brain regions when people made ...
... experience symptoms described as transient neurological attacks, such ... higher risk for stroke and dementia, according to ... JAMA. , Transient neurological attacks (TNAs) are ... symptoms. These symptoms can be nonfocal (that can ...
... Early practice for youngsters can reduce risk of shoulder ... News) -- Playing catch with your young pitcher months before ... pitfall: torn rotator cuff injuries, according to doctors at Methodist ... - a high pitch count and throwing curve balls -- ...
... those that pose a threat, experts warn , MONDAY, ... toys has attracted a great deal of attention lately, it,s ... to children. For example, some toys can damage children,s eyes, ... more than 210,000 toy-related injuries treated in U.S. emergency rooms ...
... (Nasdaq:,QMED) today announced that it has received a letter ... the bid price of the Company,s common,stock has closed ... under Marketplace Rule 4310(c)(4) (the "Rule").,Therefore, in accordance with ... 180 calendar days, or until June 16, 2008 to ...
... Chindex International,Inc. (Nasdaq: CHDX ), an independent ... the People,s Republic of China, announced today it,has ... its common stock on,the NASDAQ Global Market. Transfer ... the NASDAQ Global Market has been completed and ...
Other Medicine News:Health News:Brain imaging and genetic studies link thinking patterns to addiction 2Health News:Brain imaging and genetic studies link thinking patterns to addiction 3Health News:Some types of temporary neurological problems associated with increased risk for stroke, dementia 2Health News:Some types of temporary neurological problems associated with increased risk for stroke, dementia 3Health News:Playing Catch in Winter Could Save Kids' Pitching Arms 2Health News:Beware Holiday Toys That Can Injure Young Eyes 2Health News:QMed, Inc. Receives NASDAQ Letter 2Health News:Chindex International, Inc. Announces Transfer to NASDAQ Global Market 2Health News:Chindex International, Inc. Announces Transfer to NASDAQ Global Market 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: